Your browser doesn't support javascript.
loading
SLC14A1 gene sequencing shows the JK*01W.06 allele in a JK1 patient with an anti-JK1.
Soleimani, Reza; Cabo, Julien; Frelik, Alex; Debry, Cécile; Mbende, Catherine; Delcourt, Jacques; Debortoli, Nicolas; Renguet, Edith; Devey, Anaïs; Mullier, François; Degosserie, Jonathan; Moreno Y Banuls, Laetitia.
Afiliação
  • Soleimani R; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Hematology-Hemostasis Laboratory/Laboratory of Clinical Biology, CHU UCL Namur, Yvoir, Belgium. Electronic add
  • Cabo J; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Hematology-Hemostasis Laboratory/Laboratory of Clinical Biology, CHU UCL Namur, Yvoir, Belgium.
  • Frelik A; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
  • Debry C; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
  • Mbende C; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium.
  • Delcourt J; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
  • Debortoli N; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Namur Molecular Tech, CHU UCL Namur, Yvoir, Belgium.
  • Renguet E; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Namur Molecular Tech, CHU UCL Namur, Yvoir, Belgium.
  • Devey A; Hospital Blood Transfusion Service, CHU de Liège, Liège, Belgium.
  • Mullier F; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Hematology-Hemostasis Laboratory/Laboratory of Clinical Biology, CHU UCL Namur, Yvoir, Belgium; Namur Thrombos
  • Degosserie J; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium; Namur Molecular Tech, CHU UCL Namur, Yvoir, Belgium; Namur Research Institute for Life Sciences (NARILIS), Univeristy of Namur, Namur, Belgium.
  • Moreno Y Banuls L; Hospital Blood Transfusion Service and Donor Blood Center, CHU UCL Namur, Yvoir, Belgium; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
Hematol Transfus Cell Ther ; 2023 Dec 17.
Article em En | MEDLINE | ID: mdl-38177058
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de publicação: Brasil
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de publicação: Brasil